MARKET

EWTX

EWTX

Edgewise Therapeutics, Inc.
NASDAQ
11.51
-2.07
-15.24%
Pre Market: 11.95 +0.44 +3.82% 04:30 04/07 EDT
OPEN
12.67
PREV CLOSE
13.58
HIGH
13.28
LOW
11.50
VOLUME
43
TURNOVER
0
52 WEEK HIGH
38.12
52 WEEK LOW
11.50
MARKET CAP
1.21B
P/E (TTM)
-7.9489
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at EWTX last week (0331-0404)?
Weekly Report · 30m ago
Major Stake Acquisitions Signal Confidence in Edgewise Therapeutics
TipRanks · 2d ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 2d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 3d ago
Edgewise Therapeutics Price Target Cut to $52.00/Share From $56.00 by RBC Capital
Dow Jones · 3d ago
Edgewise Therapeutics Is Maintained at Outperform by RBC Capital
Dow Jones · 3d ago
RBC Capital Maintains Outperform on Edgewise Therapeutics, Lowers Price Target to $52
Benzinga · 3d ago
Edgewise Therapeutics downgraded at Scotiabank on heart disease trial results
Seeking Alpha · 3d ago
More
About EWTX
More
Edgewise Therapeutics, Inc. is a muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company’s lead product candidate, sevasemten (EDG-5506), is an orally administered skeletal myosin inhibitor in late-stage clinical trials in Becker and Duchenne muscular dystrophies. Its EDG-7500 is a novel cardiac sarcomere modulator for the treatment of hypertrophic cardiomyopathy and other diseases of diastolic dysfunction, which is in Phase II clinical development. The Company is using its proprietary drug discovery platform to develop a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address a broad array of serious muscle disorders. Its platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue.
Recently
Symbol
Price
%Change

Webull offers Edgewise Therapeutics Inc stock information, including NASDAQ: EWTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EWTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EWTX stock methods without spending real money on the virtual paper trading platform.